Prader-Willi syndrome is a rare genetic disease that causes poor feeding in infancy but later triggers insatiable hunger.

In a comprehensive Genomic Press Invited Expert Review, researchers from the University of Haifa have synthesized ...

May 15 marks National Prader-Willi Syndrome Awareness Day. For one Virginia father, the date is more than just a spot on the ...

HAIFA, Israel, 20 May 2025 – In a comprehensive Genomic Press Invited Expert Review, researchers from the University of Haifa have synthesized cutting-edge findings on Prader-Willi syndrome (PWS ...

In a comprehensive Genomic Press Invited Expert Review, researchers from the University of Haifa have synthesized ...

VYKAT XR was approved by the U.S. Food and Drug Administration (FDA) on March 26, 2025, and is now commercially available to ...

Aardvark Therapeutics, Inc. announced progress in its Phase 3 HERO trial for ARD-101, aimed at treating hyperphagia associated with Prader-Willi Syndrome, with data expected in early 2026.

The data concerns its product VYKAT XR, an extended-release tablet designed to treat hyperphagia in individuals with Prader-Willi syndrome (PWS). The study findings indicated that patients with ...

VYKAT XR was approved by the U.S. Food and Drug Administration (FDA) on March 26, 2025, and is now commercially available to ...

Details of the presentations are as follows: The Prader-Willi Syndrome Association USA estimates that PWS occurs in one in every 15,000 live births. The hallmark symptom of this disorder is ...